Literature DB >> 35960461

Natural remedies for Alzheimer's disease: A systematic review of randomized controlled trials.

Saara Ahmad1, Saad Bilal Ahmed2, Asra Khan3, Muhammad Wasim3, Saiqa Tabassum4,5, Saida Haider4, Fatima Ahmed6, Zehra Batool7, Saima Khaliq8, Hamna Rafiq3, Prashant Tikmani3, Anwar-Ul-Hassan Gilani3.   

Abstract

Alzheimer's disease (AD) is the common type of dementia and is currently incurable. Existing FDA-approved AD drugs may not be effective for everyone, they cannot cure the disease nor stop its progression and their effects diminish over time. Therefore, the present review aimed to explore the role of natural alternatives in the treatment of AD. A systematic search was conducted using Ovid MEDLINE, CINAHL, Cochrane and PubMed databases and reference lists up to November 30, 2021. Only randomized control trials were included and appraised using the National Institute of Health framework. Data analysis showed that herbs like Gingko Biloba, Melissa Officinalis, Salvia officinalis, Ginseng and saffron alone or in combination with curcumin, low-fat diet, NuAD-Trail, and soy lecithin showed significant positive effects on AD. Moreover, combination of natural and pharmaceuticals has far better effects than only allopathic treatment. Thus, different herbal remedies in combination with FDA approved drugs are effective and more promising in treatment of AD.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Alzheimer's disease; Cognition; Herbs; Randomized clinical trial

Year:  2022        PMID: 35960461     DOI: 10.1007/s11011-022-01063-9

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.655


  77 in total

Review 1.  Herbal medicine in the treatment of Alzheimer's disease.

Authors:  Shahin Akhondzadeh; Seyed Hesameddin Abbasi
Journal:  Am J Alzheimers Dis Other Demen       Date:  2006 Mar-Apr       Impact factor: 2.035

2.  GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. i. rationale, design and baseline data.

Authors:  Sandrine Andrieu; Pierre-Jean Ousset; Nicola Coley; Mehemed Ouzid; Hélène Mathiex-Fortunet; Bruno Vellas
Journal:  Curr Alzheimer Res       Date:  2008-08       Impact factor: 3.498

3.  Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment.

Authors:  Jennifer L Bayer-Carter; Pattie S Green; Thomas J Montine; Brian VanFossen; Laura D Baker; G Stennis Watson; Laura M Bonner; Maureen Callaghan; James B Leverenz; Brooke K Walter; Elaine Tsai; Stephen R Plymate; Nadia Postupna; Charles W Wilkinson; Jing Zhang; Johanna Lampe; Steven E Kahn; Suzanne Craft
Journal:  Arch Neurol       Date:  2011-06

Review 4.  Berberine and neurodegeneration: A review of literature.

Authors:  Touqeer Ahmed; Anwar-Ul-Hassan Gilani; Mohammad Abdollahi; Maria Daglia; Seyed Fazel Nabavi; Seyed Mohammad Nabavi
Journal:  Pharmacol Rep       Date:  2015-03-18       Impact factor: 3.024

5.  Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial.

Authors:  S Akhondzadeh; M Shafiee Sabet; M H Harirchian; M Togha; H Cheraghmakani; S Razeghi; S Sh Hejazi; M H Yousefi; R Alimardani; A Jamshidi; F Zare; A Moradi
Journal:  J Clin Pharm Ther       Date:  2010-10       Impact factor: 2.512

6.  Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial.

Authors:  S Akhondzadeh; M Noroozian; M Mohammadi; S Ohadinia; A H Jamshidi; M Khani
Journal:  J Clin Pharm Ther       Date:  2003-02       Impact factor: 2.512

7.  A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease.

Authors:  Shahin Akhondzadeh; Mehdi Shafiee Sabet; Mohammad Hossein Harirchian; Mansoreh Togha; Hamed Cheraghmakani; Soodeh Razeghi; Seyyed Shamssedin Hejazi; Mohammad Hossein Yousefi; Roozbeh Alimardani; Amirhossein Jamshidi; Shams-Ali Rezazadeh; Aboulghasem Yousefi; Farhad Zare; Atbin Moradi; Ardalan Vossoughi
Journal:  Psychopharmacology (Berl)       Date:  2009-10-20       Impact factor: 4.530

8.  Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration.

Authors:  Stephen Beatty; Usha Chakravarthy; John M Nolan; Katherine A Muldrew; Jayne V Woodside; Frances Denny; Michael R Stevenson
Journal:  Ophthalmology       Date:  2012-12-06       Impact factor: 12.079

Review 9.  Therapeutic potential of turmeric in Alzheimer's disease: curcumin or curcuminoids?

Authors:  Touqeer Ahmed; Anwarul-Hassan Gilani
Journal:  Phytother Res       Date:  2013-07-19       Impact factor: 5.878

10.  Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada.

Authors:  Thibault B Ali; Thomas R Schleret; Brian M Reilly; Winston Yuchen Chen; Ruben Abagyan
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.